Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
AbCellera Biologics Inc
Swot
AbCellera Biologics Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
AbCellera Biologics Inc has 22 Strengths, 9 Weaknesses, 5 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(22)
Weakness
(9)
Opportunity
(5)
Threats
(1)
Others
(0)
Positive Breakout Third Resistance ( LTP > R3)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Rising Momentum: Momentum Score Weekly Gainers
Companies with 10% increase in share price over three months, with rising net profit growth
High Normalized Momentum Score
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over the Quarter (3 Months)
Relative Outperformance versus Industry over 1 Year
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Positive Breakout (LTP > R2)
Positive breakout third resistance ( LTP > R3)
Companies with Low Debt
Positive Breakout (LTP > R1)
Top Gainers
Stock with Low PE (PE < = 10)
Negative to Positive growth in Sales and Profit with Strong Price momentum
Volume Shockers
Highest Recovery from 52 Week Low
Stocks Outperforming their Industry Price Change in the Quarter
Momentum Trap (DVM)
PEG greater than Industry PEG
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts
Mutual Funds Increased Shareholding in Past Month
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
Institutions decreased their shareholding last quarter
